Rodica Van Solingen‐Ristea

Also affiliated with Janssen (Belgium), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Johnson & Johnson (Germany), Johnson & Johnson (Brazil), University of Brescia

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study”.

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad020

N/A

0DataRank · unranked

128 citations

Gary Richmond, Giuliano Rizzardini, Anders Thalme, Pierre‐Marie Girard, Alexander Wong +20 more